Subthalamic Nucleus Deep Brain Stimulation in Early-onset Parkinson’s Disease: Clinical Outcomes in LRRK2 Mutation Carriers Compared to Non-Carriers
Open Access
- 1 September 2025
- journal article
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (5) , 941-948
Abstract
Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for early-onset Parkinson’s disease (EOPD). While the effect of STN-DBS on patients with LRRK2 G2019S mutation has been largely investigated, data specific to EOPD patients with this mutation remain scarce. This study examines the impact of the LRRK2 G2019S ...Keywords
This publication has 25 references indexed in Scilit:
- LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysisParkinsonism & Related Disorders, 2015
- A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonismNeurobiology of Aging, 2014
- The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleusParkinsonism & Related Disorders, 2014
- Sustained Response to Deep Brain Stimulation in LRRK2 Parkinsonism with the Y1699C MutationJournal of Parkinson’s Disease, 2012
- Quality of life in young‐ compared with late‐onset Parkinson's diseaseMovement Disorders, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- A Randomized Trial of Deep-Brain Stimulation for Parkinson's DiseaseNew England Journal of Medicine, 2006
- Levodopa‐dyskinesia incidence by age of Parkinson's disease onsetMovement Disorders, 2005
- Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/EthnicityAmerican Journal of Epidemiology, 2003
- Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)Movement Disorders, 1999